DrugPatentWatch Database Preview
Details for Patent: 7,198,801
Which drugs does patent 7,198,801 protect, and when does it expire?
Patent 7,198,801 protects ELESTRIN and GELNIQUE 3% and is included in two NDAs.
This patent has fifty-three patent family members in eighteen countries.
Summary for Patent: 7,198,801
| Title: | Formulations for transdermal or transmucosal application |
| Abstract: | The present invention relates generally to formulations for transdermal or transmucosal administration of an active agent. The invention is a substantially malodorous-free and irritation free transdermal formulation which is substantially free of long chain fatty alcohols, long-chain fatty acids, and long-chain fatty esters. |
| Inventor(s): | Carrara; Dario Norberto R. (Oberwil, CH), Grenier; Arnaud (Steinbrunn le Haut, FR), Besse; Celine (Saint Louis, FR), Simes; Stephen M. (Long Grove, IL), Lehman; Leah M. (Green Oaks, IL) |
| Assignee: | Antares Pharma IPL AG (Zug, CH) |
| Application Number: | 10/798,161 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 7,198,801 |
|
Patent Claim Types: see list of patent claims | Formulation; Compound; Delivery; |
Drugs Protected by US Patent 7,198,801
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mylan Speciality Lp | ELESTRIN | estradiol | GEL, METERED;TRANSDERMAL | 021813-001 | Dec 15, 2006 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | ||||
| Allergan Sales Llc | GELNIQUE 3% | oxybutynin | GEL, METERED;TRANSDERMAL | 202513-001 | Dec 7, 2011 | DISCN | Yes | No | Start Trial | Start Trial | Y | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 7,198,801
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| PCT/EP00/07533 | Aug 03, 2000 | |
International Family Members for US Patent 7,198,801
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 030312 | Start Trial | |||
| Austria | 355854 | Start Trial | |||
| Austria | 356636 | Start Trial | |||
| Austria | 485837 | Start Trial | |||
| Austria | 534373 | Start Trial | |||
| Australia | 2001282064 | Start Trial | |||
| Australia | 2004220498 | Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
